If Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting Started
Key PointsCancer vaccine intismeran has been highly effective in clinical trials when paired with Merck's Keytruda.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.